Protein engineering
Applying our industry-leading engineering capabilities to our next generation bispecific antibodies through the use of our autoregulation platform ensures our pipeline products can achieve the maximum efficacy in clinic whilst crucially maintaining the highest levels of patient safety.
Coupling this with our proactive and nimble approach to drug discovery and development maximises the potential of our clinic and pre-clinical portfolio.